![]() |
市場調查報告書
商品編碼
1970709
內視鏡手術器材市場-全球產業規模、佔有率、趨勢、機會、預測:按產品、最終用途、地區和競爭對手分類,2021-2031年Endoscopy Operative Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End Use, By Region & Competition, 2021-2031F |
||||||
全球內視鏡手術器材市場預計將從 2025 年的 470.3 億美元成長到 2031 年的 604.1 億美元,複合年成長率為 4.26%。
這些專用器械透過內視鏡用於組織取樣、止血和腔內解剖等治療性介入。市場成長的主要促進因素包括消化器官系統惡性腫瘤發生率的上升、對微創手術以縮短住院時間的強勁需求,以及全球人口老化導致需要進行更多手術。根據美國癌症協會預測,到2025年,美國預計將新增107,320例大腸癌病例和46,950例直腸癌病例,凸顯了對有效外科解決方案的巨大需求。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 470.3億美元 |
| 市場規模:2031年 | 604.1億美元 |
| 複合年成長率:2026-2031年 | 4.26% |
| 成長最快的細分市場 | 一次性手術器械 |
| 最大的市場 | 北美洲 |
然而,醫療設備的再處理和感染控制方面存在許多挑戰,阻礙了市場擴張。可重複使用器械的複雜設計使得消毒變得困難,增加了交叉感染和病患感染的風險。這個問題迫使醫療機構承擔高昂的消毒營運成本,並遵守嚴格的監管規定,這可能會限制這些技術的廣泛應用。
將人工智慧 (AI) 和機器學習技術應用於內視鏡成像,透過提高診斷準確性和操作效率,正在革新市場。這些先進的演算法能夠即時識別潛在的異常情況(例如結腸息肉),從而幫助臨床醫生減少漏診,並規範手術流程。例如,Medtronic在 2024 年 4 月舉行的 Genius Summit 2024 新聞稿中指出,其 ColonPRO 軟體的應用使假陽性率降低了 9%,顯著提高了基於 AI 的息肉檢測準確性,這便是這些創新技術有效性的一個例證。這項技術進步也得益於強勁的產業表現。例如,波士頓科學公司在 2024 年公佈,其內視鏡業務在 2023 會計年度實現了 24.82 億美元的淨銷售額。
同時,一次性內視鏡需求的不斷成長正在改變市場格局,直接降低了可重複使用設備帶來的感染風險。傳統器械需要嚴格且高成本的再處理程序來防止交叉感染,而一次性器械則有效消除了這一難題,並確保每位患者的器械都處於無菌狀態。這項轉變的驅動力在於不斷提高的病人安全標準以及降低醫院消毒相關營運成本的需求。近期行業趨勢表明,這些消毒解決方案正在迅速普及。根據Amb公司於2024年11月發布的《2023/24年度報告》,內視鏡解決方案業務的全年有機收入成長了19.7%,證實了市場對一次性手術器械的需求正在加速成長。
醫療設備的再處理和感染控制方面面臨的重大挑戰直接阻礙了全球內視鏡手術器材市場的成長。可重複使用的內視鏡器械內部結構複雜,難以徹底清潔,持續有交叉感染和相關病患感染的風險。這種複雜性迫使醫療機構實施嚴格且耗時的消毒通訊協定,降低了病患處理能力,並顯著增加了營運成本。
這些營運負擔因難以遵守嚴格的安全法規而進一步加劇,使醫療機構經常面臨合規風險。據聯合委員會(The Joint Commission)稱,2024年,「醫療設備的高級別消毒和滅菌標準是醫院認證調查中最常被提及的五大不合規要求之一」。這項統計數據凸顯了醫療機構在達到安全標準方面所面臨的許多挑戰。因此,感染風險管理和法規遵循所需的大量資源正在擠壓新手術器械的採購預算,阻礙這些技術的應用,並限制整體市場擴張。
機器人輔助內視鏡手術平台的快速普及正在改變外科手術格局,使外科醫生能夠在難以觸及的解剖區域進行精準干預。這些機器人系統具有卓越的靈活性和穩定性,使外科醫生能夠比傳統手動技術更精確地完成複雜的解剖和組織採集。隨著臨床療效的提升和系統應用範圍的擴大,這種向機械輔助的轉變正在迅速發展。根據2024年10月《醫療器材發展》(Medical Device Developments)雜誌的報導“Intuitive公司報告2024年第三季淨收入成長36%”,2024年第三季度Ion手術量成長約73%,這印證了這些先進技術的應用,並反映了市場對機器人內視鏡解決方案的激增需求。
同時,複雜內視鏡手術向門診手術中心(ASC)的轉移正在推動醫療服務分散化和醫療成本最佳化。微創器械和麻醉技術的進步使得在門診環境下安全地進行先進治療成為可能,與住院治療相比,顯著降低了成本。醫療機構正積極推動這項轉變,旨在增加低成本環境下的手術量。根據泰尼特醫療集團(Tenet Healthcare)2024年10月發布的新聞稿《泰尼特公佈2024年第三季強勁業績》,由聯合外科夥伴國際公司(United Surgical Partners International)運營的門診診所淨營業收入成長21.0%,達到11.39億美元,印證了診所選址轉移帶來的顯著經濟效益。
The Global Endoscopy Operative Devices Market is projected to expand from USD 47.03 Billion in 2025 to USD 60.41 Billion by 2031, reflecting a CAGR of 4.26%. These specialized instruments are utilized through endoscopes to perform therapeutic interventions, such as tissue retrieval, hemostasis, and dissection within internal lumens. Market growth is primarily driven by the rising incidence of gastrointestinal malignancies, a strong preference for minimally invasive surgeries that reduce hospital stays, and an aging global population requiring more procedures. According to the 'American Cancer Society', in '2025', 'approximately 107,320 new cases of colon cancer and 46,950 new cases of rectal cancer are estimated to be diagnosed in the United States', underscoring the critical demand for effective operative solutions.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 47.03 Billion |
| Market Size 2031 | USD 60.41 Billion |
| CAGR 2026-2031 | 4.26% |
| Fastest Growing Segment | Disposable Operative Devices |
| Largest Market | North America |
However, market expansion is hindered by the significant challenge of device reprocessing and infection control. The complex design of reusable instruments complicates sterilization, increasing the risk of cross-contamination and subsequent patient infections. This issue forces healthcare providers to bear high operational costs for decontamination and adhere to strict regulatory compliance, which potentially restricts the broader adoption of these technologies.
Market Driver
The integration of artificial intelligence and machine learning in endoscopic imaging is revolutionizing the market by enhancing diagnostic precision and operational efficiency. These advanced algorithms assist clinicians in real-time by identifying potential abnormalities like colorectal polyps, thereby reducing missed diagnoses and standardizing procedure quality. Highlighting the efficacy of such innovations, Medtronic reported in their April 2024 'Genius Summit 2024' press release that the launch of their ColonPRO software demonstrated a 9% reduction in false positives, significantly improving AI-driven polyp detection. This technological advancement is supported by robust sector performance; for instance, Boston Scientific reported in 2024 that their endoscopy business generated net sales of $2.482 billion for the full year 2023.
Simultaneously, the increasing demand for single-use and disposable endoscopes is reshaping the market landscape by directly mitigating infection risks associated with reusable devices. Traditional instruments require rigorous and costly reprocessing procedures to prevent cross-contamination, a challenge that single-use alternatives effectively eliminate while ensuring sterility for every patient. This shift is driven by the need to improve patient safety standards and reduce hospital operational expenditures related to decontamination. The rapid adoption of these sterile solutions is evident in recent industry performance; according to Ambu's November 2024 'Annual Report 2023/24', organic revenue for their Endoscopy Solutions segment increased by 19.7% for the full year, underscoring the accelerating preference for disposable operative devices.
Market Challenge
The significant challenge of device reprocessing and infection control is directly hampering the growth of the Global Endoscopy Operative Devices Market. Reusable endoscopic instruments feature intricate internal channels and complex designs that are difficult to clean thoroughly, creating a persistent risk of cross-contamination and subsequent patient infections. This complexity forces healthcare facilities to implement rigorous, time-consuming decontamination protocols that reduce patient throughput and substantially increase operational expenditures.
These operational burdens are compounded by the difficulty of maintaining adherence to stringent safety regulations, which frequently exposes providers to compliance risks. According to 'The Joint Commission', in '2024', 'standards regarding the high-level disinfection and sterilization of medical equipment were identified as one of the top five most frequently cited non-compliant requirements during hospital accreditation surveys'. This statistic highlights the widespread struggle healthcare organizations face in meeting safety expectations. Consequently, the significant resources required to manage infection risks and ensure regulatory compliance divert budget allocations away from the procurement of new operative devices, thereby impeding the broader adoption of these technologies and restricting overall market expansion.
Market Trends
The accelerated deployment of robot-assisted endoscopic surgical platforms is altering the operative landscape by enabling precise intervention in difficult-to-reach anatomical regions. These robotic systems provide enhanced dexterity and stability, allowing surgeons to perform complex dissections and tissue retrievals with greater accuracy than traditional manual techniques. This shift towards mechanized assistance is rapidly gaining traction as clinical outcomes improve and system utilization expands globally. According to Medical Device Developments, October 2024, in the 'Intuitive reports 36% increase in Q3 2024 net income' article, the adoption of such advanced technologies was evidenced by an approximate 73% growth in Ion procedure volume for the third quarter of 2024, reflecting the surging demand for robotic endoluminal solutions.
Simultaneously, the migration of complex endoscopic procedures to Ambulatory Surgical Centers (ASCs) is decentralizing care delivery and optimizing healthcare expenditures. Advancements in minimally invasive instruments and anesthesia now permit high-acuity interventions to be safely performed in outpatient settings, offering significant cost savings compared to inpatient hospital admissions. This transition is actively pursued by healthcare operators seeking to capture increased case volumes in lower-cost environments. According to Tenet Healthcare, October 2024, in the 'Tenet Reports Strong Third Quarter 2024 Results' press release, their Ambulatory Care segment operated by United Surgical Partners International achieved a net operating revenue increase of 21.0% to $1.139 billion, underscoring the substantial financial scale of this venue shift.
Report Scope
In this report, the Global Endoscopy Operative Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Endoscopy Operative Devices Market.
Global Endoscopy Operative Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: